Sign inJoin waitlistJoin the waitlist

JN

Jerry Nick

Physician · National Jewish Health

Credentials: · · ·

History

National Jewish Health
Present

Pulmonary Disease and Critical Care Medicine
University of Colorado School of Medicine
1993–1997
Internal Medicine
University of Washington-Seattle Campus
1989–1992
University of Washington School of Medicine
1985–1989

Research

By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation
Cell · 2003 · 542 citations
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
Thorax · 2016 · 367 citations
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
Clinical Infectious Diseases · 2023 · 287 citations

MS
Milene Saavedra
25 papers
CD
Charles Daley
22 papers
DN
David Nichols
22 papers
Stacey Martiniano
20 papers · 1 as a fellow
George Worthen
19 papers
Jennifer Taylor-Cousar
17 papers
Scott Sagel
11 papers
Michael Fessler
9 papers
Jane Gross
8 papers
Katie Hisert
8 papers
George Solomon
7 papers · 2 as a fellow
Kara Calhoun
7 papers · 1 as a fellow

Grants

A Phase 1b, Multi-Center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis Who Are Colonized with Nontuberculosis Mycobacterium (The ABATE Study).
Food and Drug Administration · R01
PI · $3.1M · Seattle Children's Hospital
2020–2027
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · National Jewish Health
2019–2023
Viral-Induced Adaptation of Neutrophil Response in ARDS
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · National Jewish Health
2007–2012
Heterogeneous Neutrophil Responses in Acute Lung Injury
National Heart, Lung, and Blood Institute · P01
Project lead · $997.6K · University of Colorado Denver
2002–2006

Clinical trials

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
Principal investigator · Enrolling by invitation
National Jewish Health
2024–2028
Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographY
Principal investigator · Unknown
National Jewish Health
2023
Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening
Principal investigator · Enrolling by invitation
Jerry A. Nick, M.D.
2020–2026
Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection
Principal investigator · Terminated · Phase 2
Savara Inc.
2019–2020